PharmiWeb.com - Global Pharma News & Resources

Research and development - Press Releases

Date Title Company
29-Mar-2023 CD Formulation Provides Pharmaceutical Testing on Tablet Fragility, Dissolution, and Disintegration CD Formulation
28-Mar-2023 Women Leaders Coming Together for Fourth Annual Medtech Conference MedExecWomen
28-Mar-2023 MIMETAS and Astellas Enter into Strategic Partnership on Immuno-Oncology MIMETAS
28-Mar-2023 MaxBio+ creates an insulin spray – heralding an end to insulin needles MaxBio+
28-Mar-2023 softgate joins BlackBerry Value-Added Integrator Program To Accelerate Safety-Critical Medical Software Innovation softgate
28-Mar-2023 InfanDx AG Revises Strategy and Broadens Diagnostics Pipeline for Child Health InfanDx
28-Mar-2023 Tavneos® (avacopan) included in updated EULAR recommendations for the management of AAV Vifor Fresenius Medical Care Renal Pharma
28-Mar-2023 Tavneos® (avacopan) included in updated EULAR recommendations for the management of AAV Vifor Fresenius Medical Care Renal Pharma
28-Mar-2023 SmiLe Incubator first in the Nordics to receive digital kiosk from Merck SmiLe Incubator
28-Mar-2023 PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award PharmaBlock
27-Mar-2023 PharmaBlock Opens New R&D Facility in Pennsylvania -- Expanding Capacity to Deliver GMP Projects PharmaBlock
27-Mar-2023 Helix VaxApp gets approval from NHS England to boost vaccine management Telstra Health UK
27-Mar-2023 HpVac reports positive effects of its lead compound HpVac-R13 in a murine model of allergic asthma following oral administration HpVac
23-Mar-2023 Harnessing power of immune system may lessen reliance on antibiotics for infections like TB Francis Crick Institute
23-Mar-2023 Vaccination halves risk of long Covid, largest study to date shows University of East Anglia
23-Mar-2023 Curia Collaborates with Corning to Advance Biopharmaceutical Continuous-Flow Development and Manufacturing Programs Curia
23-Mar-2023 Is it time to reimagine patient information? New report shows that patients are turning to alternative sources for medicines information as only 32% of respondents fully understand their medicine’s label Pfizer
23-Mar-2023 SYMBICORT (budesonide/formoterol) TURBOHALER 200/6 APPROVED AS FIRST AND ONLY COMBINATION RELIEVER FOR MILD ASTHMA IN THE UK AstraZeneca
23-Mar-2023 NICE publishes guidance recommending Bayer’s Kerendia® (finerenone) as an option for treating adult patients with chronic kidney disease associated with type 2 diabetes Bayer
23-Mar-2023 EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis EVERSANA®